86 related articles for article (PubMed ID: 8150542)
1. Relationship between loss of estrogen and progesterone receptor expression and of 6q and 11q chromosome arms in breast cancer.
Magdelénat H; Gerbault-Seureau M; Dutrillaux B
Int J Cancer; 1994 Apr; 57(1):63-6. PubMed ID: 8150542
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
[TBL] [Abstract][Full Text] [Related]
4. Genetic evolution of breast cancer: II. Relationship with estrogen and progesterone receptor expression.
Magdelenat H; Gerbault-Seureau M; Laine-Bidron C; Prieur M; Dutrillaux B
Breast Cancer Res Treat; 1992; 22(2):119-27. PubMed ID: 1391976
[TBL] [Abstract][Full Text] [Related]
5. The loss of estrogen and progesterone receptor gene expression in human breast cancer.
Lapidus RG; Nass SJ; Davidson NE
J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):85-94. PubMed ID: 10819507
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of the DNA binding domain of the estrogen receptor gene in ER (+)/PR (-) breast cancer.
Mies C; Voigt W
Diagn Mol Pathol; 1996 Mar; 5(1):39-44. PubMed ID: 8919544
[TBL] [Abstract][Full Text] [Related]
7. Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array study.
Carracedo A; Salido M; Corominas JM; Rojo F; Ferreira BI; Suela J; Tusquets I; Corzo C; Segura M; Espinet B; Cigudosa JC; Arumi M; Albanell J; Serrano S; Solé F
Cancer Genet; 2012 Apr; 205(4):138-46. PubMed ID: 22559974
[TBL] [Abstract][Full Text] [Related]
8. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation pattern of ESR and PgR genes and lacking estrogen and progesterone receptors in human breast cancer tumors: ER/PR subtypes.
Pirouzpanah S; Taleban FA; Mehdipour P; Sabour S; Atri M
Cancer Biomark; 2018 Feb; 21(3):621-638. PubMed ID: 29278880
[TBL] [Abstract][Full Text] [Related]
10. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients.
Seute A; Sinn HP; Schlenk RF; Emig R; Wallwiener D; Grischke EM; Hohaus S; Döhner H; Haas R; Bentz M
Int J Cancer; 2001 Jul; 93(1):80-4. PubMed ID: 11391625
[TBL] [Abstract][Full Text] [Related]
12. Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
Tutera AM; Sellers TA; Potter JD; Drinkard CR; Wiesner GL; Folsom AR
Genet Epidemiol; 1996; 13(2):207-21. PubMed ID: 8722747
[TBL] [Abstract][Full Text] [Related]
13. Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma.
Davis LM; Harris C; Tang L; Doherty P; Hraber P; Sakai Y; Bocklage T; Doeden K; Hall B; Alsobrook J; Rabinowitz I; Williams TM; Hozier J
J Mol Diagn; 2007 Jul; 9(3):327-36. PubMed ID: 17591932
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
[TBL] [Abstract][Full Text] [Related]
15. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
[TBL] [Abstract][Full Text] [Related]
16. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features.
Nagai MA; Marques LA; Yamamoto L; Fujiyama CT; Brentani MM
Int J Cancer; 1994 Nov; 59(3):351-6. PubMed ID: 7927940
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles in breast tumors regarding the presence or absence of estrogen and progesterone receptors.
Nagai MA; Da Rós N; Neto MM; de Faria Junior SR; Brentani MM; Hirata R; Neves EJ
Int J Cancer; 2004 Oct; 111(6):892-9. PubMed ID: 15300801
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.
Chappell SA; Walsh T; Walker RA; Shaw JA
Br J Cancer; 1997; 75(9):1324-9. PubMed ID: 9155053
[TBL] [Abstract][Full Text] [Related]
20. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
